FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs

Feb. 26, 2009--The U.S. Food and Drug Administration announced today that manufacturers of metoclopramide, a drug used to treat gastrointestinal disorders, must add a boxed warning to their drug labels about the risk of its long-term or high-dose use.

The details can be read here.